Skip to content

Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients

Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06194474
Enrollment
24
Registered
2024-01-08
Start date
2022-09-05
Completion date
2024-02-29
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium

Brief summary

To evaluate the relationship between abnormal protein or metabolite expression levels in peripheral blood and postoperative delirium in elderly patients undergoing cardiac surgery.

Interventions

None listed

Sponsors

Jining First People's Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. patients between 55 and 80 years old, 2. American Society of Anesthesiologists (ASA) physical status of II-III and New York Heart Association grade of II-III. 3. The planned cardiac surgery. 4. Hospitalization duration not less than 5 days. 5. The anesthesia time will be no less than 2 hours.All patients had a normal ability to hear, read and cooperate with neuropsychological tests.

Exclusion criteria

1. The pre-operative Montreal Cognitive Assessment (MoCA) score was less than 25, 2. Patients with dementia, history of neurological or psychiatric disease, hospital with anxiety depression scale (HADS) over eight points, 3. Currently use sedatives or antidepressants, Patients with substance dependence on drugs or alcohol. 4. Patients with liver and kidney dysfunction, patients with a history of cardiac surgery. 5. Admitted to the ICU for more than two days within the month preceding the current surgery, 6. Unable to cooperate with researcher's investigations.

Design outcomes

Primary

MeasureTime frameDescription
Proteomics1 monthProteomic data will be obtained by LC-MS/MS Analysis-DIA(Data Independent Acquisition) platform

Countries

China

Contacts

Primary ContactFuhui Yan
richardcarryon@163.com155 8733 5175

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026